ALNOV:EPA
Novacyt SA
0,44 €
arrow_downward
−0,68%(−0,0030) 1 d
19 nov., 13:12:09 GMT+1 · EUR
search
Alla symboler
| Symbol | Pris | Ändring | Ändring i procent |
|---|
insights_autoGenererar de viktigaste insikterna för ALNOV …
Öppen
0,44 €
Högt
0,44 €
Lågt
0,44 €
Börsvärde
32,08 mn
Genomsn. vol.
136,90 tn
Volym
45,82 tn
52v högst
1,04 €
52v lägst
0,29 €
EPS
−0,38 €
Utestående aktier
72,59 mn
Antal anställda
228
Öppen
0,44 €
Högt
0,44 €
Lågt
0,44 €
Börsvärde
32,08 mn
Genomsn. vol.
136,90 tn
Volym
45,82 tn
52v högst
1,04 €
52v lägst
0,29 €
EPS
−0,38 €
Utestående aktier
72,59 mn
Antal anställda
228
Nyheter och artiklar
Från webbkällor och nyhetspartner
Yahoo Finance
·
för 2 timmar sedan
Is Investing in an S&P 500 ETF Really Enough? Here's My Honest Take.
MarketWatch
·
för 24 minuter sedan
Stock Market Today: Nasdaq to lead Dow and S&P 500 higher as tech rallies on Anthropic IPO optimism; Nvidia stock gains; Walmart earnings on tap: live updates
Los Angeles Times
·
för 15 timmar sedan
A fifth straight drop for the S&P 500 drags Wall Street to its longest losing streak since June
24/7 Wall St.
·
för 21 minuter sedan
4 S&P 500 Dividend Stocks Paying Shareholders More Than Their Free Cash Flow
Profil
Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France. The company produces in vitro and molecular diagnostic tests, supplying assays and reagents worldwide. Its business units include Primerdesign, Microgen Bioproducts and Lab21 Healthcare.
In January 2020 the company announced that its molecular diagnostics division, Primerdesign, had launched a molecular test for the 2019 strain of SARSr-CoV. The test was approved as eligible for procurement under the World Health Organization's Emergency Use Listing process in April 2020, meaning that the test could be supplied by the United Nations and other procurement agencies supporting the COVID-19 response. In the same month Novacyt announced a collaboration with AstraZeneca, GlaxoSmithKline and the University of Cambridge to support the UK in its COVID-19 national screening programme at a new testing laboratory at the university's Anne McLaren laboratory. Wikipedia
Om Novacyt SA
VdDavid Allmond
Anställda228
Grundades3 juli 2006
Huvudkontor-
SektorHealth Care
Bransch-
Webbplatsnovacyt.com